These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37608295)

  • 21. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
    Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
    Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
    Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
    Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic modification of Castor zinc finger 1 (CASZ1) is associated with tumor microenvironments and prognosis of clear cell renal cell carcinoma.
    Li F; Liang J; Wei X
    Int J Surg; 2024 Sep; ():. PubMed ID: 39235847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidimensional comprehensive and integrated analysis of the potential function of TMEM25 in renal clear cell carcinoma with low expression status.
    Xi P; Zhang Z; Liu Y; Nie Y; Gong B; Liu J; Huang H; Liu Z; Sun T; Xie W
    Aging (Albany NY); 2024 Jan; 16(1):367-388. PubMed ID: 38189809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic and tumor microenvironmental feature of clear cell renal cell carcinoma revealed by m6A and lactylation modification-related genes.
    Yang L; Wang X; Liu J; Liu X; Li S; Zheng F; Dong Q; Xu S; Xiong J; Fu B
    Front Immunol; 2023; 14():1225023. PubMed ID: 37638005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma.
    Zhang X; Zhang M; Song L; Wang S; Wei X; Shao W; Song N
    Sci Rep; 2023 Nov; 13(1):20266. PubMed ID: 37985807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOBEC family reshapes the immune microenvironment and therapy sensitivity in clear cell renal cell carcinoma.
    Huang G; Zhan X; Shen L; Lou L; Dai Y; Jiang A; Gao Y; Wang Y; Xie X; Zhang J
    Clin Exp Med; 2024 Sep; 24(1):212. PubMed ID: 39249558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-Omics Analysis of the Prognosis and Biological Function for TRPV Channel Family in Clear Cell Renal Cell Carcinoma.
    Jiang Y; Han D; Zhao Y; Zhang C; Shi X; Gu W
    Front Immunol; 2022; 13():872170. PubMed ID: 35558077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A New Thinking: Deciphering the Aberrance and Clinical Implication of IGF Axis Regulation Pattern in Clear Cell Renal Cell Carcinoma.
    Jiang A; Wu X; Wang D; Wang A; Dong K; Liu B; Qu L; Luo P; Wang J; Tong Q; Wang L
    Front Immunol; 2022; 13():935595. PubMed ID: 35935986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
    Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
    J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a polyamine gene expression score for predicting prognosis and treatment response in clear cell renal cell carcinoma.
    Chen M; Nie Z; Huang D; Gao Y; Cao H; Zheng L; Zhang S
    Front Immunol; 2022; 13():1048204. PubMed ID: 36505496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma.
    Chang K; Su J; Li C; Anwaier A; Liu W; Xu W; Qu Y; Zhang H; Ye D
    Front Oncol; 2022; 12():1079446. PubMed ID: 36544704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated analysis of immune-related gene subtype and immune index for immunotherapy in clear cell renal cell carcinoma.
    Bai D; Chen S; Feng H; Yin A; Lu J; Ma Y; Sugiyama H
    Pathol Res Pract; 2021 Sep; 225():153557. PubMed ID: 34329838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
    Yue Y; Cai X; Lu C; Sechi LA; Solla P; Li S
    Front Immunol; 2023; 14():1238312. PubMed ID: 37908350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level.
    Liu Y; Qi L; Ye B; Wang A; Lu J; Qu L; Luo P; Wang L; Jiang A
    Cancer Biol Ther; 2024 Dec; 25(1):2345977. PubMed ID: 38659199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage-Specific Cathepsin as a Marker Correlated with Prognosis and Tumor Microenvironmental Characteristics of Clear Cell Renal Cell Carcinoma.
    Zhang F; Liang J; Lu Y; Tang Y; Liu S; Wu K; Zhang F; Lu Y; Liu Z; Wang X
    J Inflamm Res; 2022; 15():6275-6292. PubMed ID: 36386587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
    Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
    BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of
    Wang T; Xie F; Li YH; Liang B
    Future Oncol; 2021 Dec; 17(36):5033-5044. PubMed ID: 34704468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.